| Metric | Q2 2025 | Q1 2025 | Q2 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $318M | $283M | — | 12.4% | — |
| Op. Income | $56M | $48M | — | 18.4% | — |
| Gross Margin | 39.7% | 40.9% | — | -1.2pp | — |
| Net Margin | 5.2% | 2.8% | — | 2.5pp | — |
| EPS (Diluted) | $0.20 | $0.10 | — | 108.1% | — |
| Free Cash Flow | $54M | $31M | — | 74.7% | — |
| Item | Amount |
|---|---|
| REVENUE | $318M |
| Cost of Revenue | $191M |
| GROSS PROFIT | $126M |
| R&D Expenses | $18M |
| Selling & Marketing | $20M |
| General & Administrative | $40M |
| SG&A Expenses | $60M |
| Other Expenses | -$9M |
| Operating Expenses | $70M |
| Cost & Expenses | $261M |
| OPERATING INCOME | $56M |
| Interest Income | $11M |
| Interest Expense | $0 |
| Other Income/Expenses | -$35M |
| INCOME BEFORE TAX | $22M |
| Income Tax Expense | $5M |
| Net Income from Continuing Ops | $17M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $17M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $16M |
| D&A | $8M |
| EBIT | $48M |
| EBITDA | $55M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $318M |
| Cost of Revenue | $191M |
| GROSS PROFIT | $126M |
| R&D Expenses | $18M |
| Selling & Marketing | $20M |
| General & Administrative | $40M |
| SG&A Expenses | $60M |
| Other Expenses | -$9M |
| Operating Expenses | $70M |
| Cost & Expenses | $261M |
| OPERATING INCOME | $56M |
| Interest Income | $11M |
| Interest Expense | $0 |
| Other Income/Expenses | -$35M |
| INCOME BEFORE TAX | $22M |
| Income Tax Expense | $5M |
| Net Income from Continuing Ops | $17M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $17M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $16M |
| D&A | $8M |
| EBIT | $48M |
| EBITDA | $55M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $17M |
| Depreciation & Amortization | $8M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $40M |
| Change in Working Capital | -$7M |
| OPERATING CASH FLOW | $57M |
| Capital Expenditure | -$4M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$192M |
| Sales/Maturities of Investments | $71M |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$125M |
| Net Debt Issuance | $81M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$4M |
| NET CASH FROM FINANCING | $78M |
| FREE CASH FLOW | $54M |
| Net Change in Cash | $2M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $183M |
| Short-Term Investments | $22M |
| Net Receivables | $128M |
| Inventory | $0 |
| Other Current Assets | $24M |
| TOTAL CURRENT ASSETS | $362M |
| PP&E (Net) | $68M |
| Goodwill | $23M |
| Intangible Assets | $11M |
| Long-Term Investments | $868M |
| Tax Assets | $0 |
| Other Non-Current Assets | $67M |
| TOTAL NON-CURRENT ASSETS | $1.0B |
| TOTAL ASSETS | $1.4B |
| Account Payables | $9M |
| Short-Term Debt | $183M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $254M |
| Long-Term Debt | $544M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $26M |
| Other Non-Current Liabilities | $77M |
| TOTAL NON-CURRENT LIABILITIES | $677M |
| TOTAL LIABILITIES | $931M |
| Common Stock | $0 |
| Additional Paid-In Capital | $1.3B |
| Retained Earnings | -$919M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$33M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $367M |
| Minority Interest | $101M |
| TOTAL EQUITY | $468M |
| TOTAL LIABILITIES & EQUITY | $1.4B |
| Total Debt | $764M |
| Net Debt | $581M |
